© 2006 European Society of Cardiology
Myocardial dysfunction with increased ventricular compliance in volume overload hypertrophy
Department of Clinical Medicine Botucatu School of Medicine-UNESP, Brazil
* Corresponding author. Departamento de Clínica Médica, Faculdade de Medicina de Botucatu, UNESP 18618-000, SP, Brazil. Tel.: +55 14 68822969; fax: +55 14 68822238. E-mail address: beatrizm{at}fmb.unesp.br
 |
Abstract |
|---|
The aim this study was to evaluate systolic and diastolic function in volume overload induced myocardial hypertrophy in rats.
Volume overload myocardial hypertrophy was induced in thirteen male Wistar rats by creating infrarenal arteriovenous fistula (AVF). The results were compared with a SHAM operated group (n = 11). Eight weeks after surgery, tail-cuff blood pressure was recorded, then rats were sacrificed for isolated heart studies using Langendorff's preparation.
AVF rats presented increased left and right ventricular weights, compared to controls. The increased normalized ventricular volume (V0/LVW, 0.141 ± 0.035 mL/g vs. 0.267±0.071 mL/g, P <0.001) in the AVF group indicated chamber dilation. Myocardial hydroxyproline concentration remained unchanged. There was a significant decrease in +dP/dt (3318±352 mm Hg s–1 vs. 2769±399 mm Hg s –1; P=0,002), end-systolic pressure-volume relation (246±56 mm Hg mL–1 vs. 114±63 mm Hg mL–1; P<0,001), and –dP/dt (1746±240 mm Hg s –1 vs. 1361±217 mm Hg s –1 P<0.001) in the AVF group, which presented increased ventricular compliance (
V25: SHAM=0.172±0.05 mL vs. AVF=0.321±0.072 mL, P<0.001) with preserved myocardial passive stiffness (Strain25: SHAM=13.5±3.0% vs. AVF=12.3+1.9%, P>0.05).
We conclude that volume-overload induced hypertrophy causes myocardial systolic and diastolic dysfunction with increased ventricular compliance. These haemodynamic features help to explain the long-term compensatory phase of chronic volume overload before transition to overt congestive heart failure.
Key Words: Cardiac hypertrophy • Ventricular dilation • Volume overload • Myocardial contractility
Received April 8, 2005; Revised November 30, 2005; Accepted February 8, 2006
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Winkler, C. Wanner, C. Drechsler, J. Lilienthal, W. Marz, V. Krane, and for the German Diabetes and Dialysis Study Investi Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients Eur. Heart J., September 1, 2008; 29(17): 2092 - 2099. [Abstract] [Full Text] [PDF]
|
|